Fresenius Medical Care
Fresenius Medical Care, a leading global provider of products and services for individuals with renal diseases, is headquartered in the United States. Founded in 1996, the company has established a strong presence in North America, Europe, and Asia, focusing on dialysis services and the manufacture of dialysis equipment. With a commitment to innovation, Fresenius Medical Care offers a comprehensive range of products, including dialysis machines and consumables, which are distinguished by their advanced technology and patient-centric design. The company is recognised for its significant market position, serving millions of patients worldwide and achieving notable milestones in improving patient outcomes. As a key player in the healthcare industry, Fresenius Medical Care continues to lead in the development of integrated care solutions, enhancing the quality of life for those affected by chronic kidney disease.
DitchCarbon Score
How does Fresenius Medical Care's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Medical Care's score of 44 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fresenius Medical Care's reported carbon emissions
In 2023, Fresenius Medical Care reported total carbon emissions of approximately 656,600,000 kg CO2e, comprising 260,800,000 kg CO2e from Scope 1 and 466,600,000 kg CO2e from Scope 2 emissions. The company also disclosed Scope 3 emissions, which totalled about 395,800,000 kg CO2e. Over the years, the company has shown a commitment to reducing its carbon footprint, with a long-term target to achieve net-zero emissions by 2050 across all scopes. In 2022, the total emissions were approximately 731,300,000 kg CO2e, indicating a slight reduction in emissions in 2023. The company has been actively working on its sustainability initiatives and has committed to the Science Based Targets initiative (SBTi), reinforcing its dedication to climate action. Fresenius Medical Care's emissions data reflects its ongoing efforts to manage and reduce its environmental impact, aligning with industry standards and climate commitments. The company continues to focus on improving its operational efficiency and reducing emissions across its global operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 218,700,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Medical Care is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
